A detailed history of Black Rock Inc. transactions in Tela Bio, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 567,206 shares of TELA stock, worth $1.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
567,206
Previous 1,043,228 45.63%
Holding current value
$1.71 Million
Previous $5.92 Million 54.95%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$4.39 - $6.36 $2.09 Million - $3.03 Million
-476,022 Reduced 45.63%
567,206 $2.67 Million
Q1 2024

May 10, 2024

SELL
$5.3 - $7.61 $184,588 - $265,041
-34,828 Reduced 3.23%
1,043,228 $5.92 Million
Q4 2023

Feb 13, 2024

BUY
$4.5 - $7.51 $261,081 - $435,715
58,018 Added 5.69%
1,078,056 $7.14 Million
Q3 2023

Nov 13, 2023

BUY
$7.85 - $10.68 $66,842 - $90,940
8,515 Added 0.84%
1,020,038 $8.16 Million
Q2 2023

Aug 11, 2023

BUY
$9.23 - $11.23 $9.17 Million - $11.2 Million
992,960 Added 5349.14%
1,011,523 $10.2 Million
Q1 2023

May 12, 2023

SELL
$9.41 - $12.03 $301 - $384
-32 Reduced 0.17%
18,563 $197,000
Q4 2022

Feb 13, 2023

BUY
$6.5 - $11.5 $9,048 - $16,008
1,392 Added 8.09%
18,595 $213,000
Q3 2022

Nov 14, 2022

BUY
$7.36 - $9.15 $18,974 - $23,588
2,578 Added 17.63%
17,203 $146,000
Q2 2022

Aug 12, 2022

SELL
$5.54 - $11.49 $37,660 - $78,109
-6,798 Reduced 31.73%
14,625 $103,000
Q1 2022

May 12, 2022

SELL
$11.35 - $13.7 $10,998 - $13,275
-969 Reduced 4.33%
21,423 $249,000
Q4 2021

Feb 10, 2022

BUY
$11.95 - $13.34 $10,587 - $11,819
886 Added 4.12%
22,392 $287,000
Q3 2021

Nov 09, 2021

SELL
$12.2 - $15.93 $4,684 - $6,117
-384 Reduced 1.75%
21,506 $294,000
Q2 2021

Aug 11, 2021

BUY
$11.7 - $16.11 $256,112 - $352,647
21,890 New
21,890 $352,000

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $57.7M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.